Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Upcoming Earnings Report May Fail to Save the Day for Sundial Stock

Instead of buying ahead of or after earnings, wait for a reverse split before buying. It may result in shares plunging to a discount to tangible book, making SNDL stock both a value play and a moonshot play.

Warner Bros. Discovery Stock Could Pay Off, But Patience Is Key

With high upside potential if it delivers on promises of revenue/cost synergies, consider WBD stock a buy after its recent weakness.

Mullen Automotive Battery News Is Doing Little to Recharge Excitement

In avoiding shares, despite the glowing press releases about its EV battery technology, it's the meme crowd has seemingly wised up. With this in mind, you may want to wise up as well, and steer clear of MULN stock.

Shiba Inu: All Bets are off as to Whether This Dog Gets Another Day

While it's not for certain Shiba Inu goes to the dogs from here, don't be so certain it's on the verge of a rally either.

Does a Low Correlation With Stocks Make Dogecoin a Buy?

Unlike Bitcoin, Dogecoin doesn't dance to the beat of the stock market's drum, which may help it out in the months ahead.

Novavax Stock Could Give Back More of Its Pandemic-Era Gains

While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium.

An Upset Victory for FuboTV Stock Is Too Far Off to Make it a Buy Today

You may think that this sports betting/streaming play is oversold, but a comeback for FUBO stock may take too long. There's no rush to bottom-fish in FUBO stock. If bullish on its future, take your time.

Steer Clear of VeChain After Its Spike on No News

Investors should pass on VeChain, as when it comes to speculative cryptocurrencies, it's best to stick with general-use picks.

7 Micro-Cap Stocks to Make a Bet on in Q2

They may be risky and under the radar, but these seven micro-cap stocks offer ample upside potential at today's prices.

The Crowd Has Wisely Soured on Cassava Sciences Stock

As perceptions rise that its flagship drug candidate won't make it to market, steer clear of SAVA stock.